Healthcare and clinical operations Operational Intelligence Review

A paid review format for Healthcare and clinical operations before a read-only pilot or live integration.

Report IDHEA-DEMO-OIR-0001

MTC2026-07-03T10:00:00Z

Local2026-07-03 12:00 CEST

BoundaryMODEL / synthetic

No customer data, no sensitive credentials, no live write, no automatic execution. Human approval remains final.

Executive Summary

P01

QuestionDoes the time between first weak signal and approved action create avoidable exposure in clinical operations continuity?
Observation range30 synthetic days, 420,000 aggregate observations, no customer data.
Candidate windows41 candidate decision windows, median 17 minutes, labelled MODEL.

Problem Groups

P02

Operational areaArea: hospital systems/bed flow/diagnostics. Raven separates signal, evidence, options and human approval.
ExposureExposure: care-path delay and escalation exposure. Results are synthetic model outputs, not guaranteed savings.
DecisionDecision: Raven recommends the path; Mira labels cost only when financial specifics appear.

Decision Model

P03

KnownKnown: time, signals, escalation path, approval state and data boundaries.
EstimatedEstimated: exposure cost, decision window and consequence range, always labelled MODEL or ESTIMATE.
UnknownUnknown: actual customer cost, SLA process and approved action policies until pilot validation.

Boundary

P04

Public-safe limitNo customer data, no sensitive credentials, no live write, no automatic execution. Human approval remains final.